MedPath

PT Bio Farma

PT Bio Farma logo
🇮🇩Indonesia
Ownership
Private
Established
1890-01-01
Employees
501
Market Cap
-
Website
http://www.biofarma.co.id

Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine in Indonesian Adults, Adolescents, Children and Infants

Phase 2
Completed
Conditions
Safety Issues
Immunogenicity
Interventions
Biological: Vi Polysaccharide Vaccine
Biological: Vi-DT Vaccine
Biological: IPV Vaccine
First Posted Date
2018-03-09
Last Posted Date
2020-02-20
Lead Sponsor
PT Bio Farma
Target Recruit Count
600
Registration Number
NCT03460405
Locations
🇮🇩

Puskesmas Jatinegara, Jakarta, Indonesia

🇮🇩

Puskesmas Senen, Jakarta, Indonesia

Safety Profile Following Td Vaccination in Indonesian Pregnant Woman

Completed
Conditions
Pregnant
Healthy
First Posted Date
2017-12-26
Last Posted Date
2018-03-06
Lead Sponsor
PT Bio Farma
Target Recruit Count
200
Registration Number
NCT03383653
Locations
🇮🇩

Jakarta Provincial Ministry of Health, Jakarta, Jakarta Province, Indonesia

Protectivity and Safety of Quadrivalent Influenza HA Vaccine in Indonesian Population

Phase 2
Completed
Conditions
Safety Issues
Interventions
Biological: Quadrivalent Influenza Vaccine
Biological: Trivalent Influenza Vaccine
First Posted Date
2017-11-08
Last Posted Date
2019-04-02
Lead Sponsor
PT Bio Farma
Target Recruit Count
810
Registration Number
NCT03336593
Locations
🇮🇩

Ibrahim Adjie Primary Health Center, Bandung, West Java, Indonesia

🇮🇩

Garuda Primary Health Center, Bandung, West Java, Indonesia

🇮🇩

Puter Primary Health Center, Bandung, West Java, Indonesia

Immunogenicity and Safety Profile of Primary Dose of bOPV Bio Farma Given Simultaneously With Pentabio And IPV

Phase 4
Completed
Conditions
Healthy
Interventions
Biological: bOPV
Biological: Pentabio
Biological: IPV
First Posted Date
2017-10-16
Last Posted Date
2017-11-08
Lead Sponsor
PT Bio Farma
Target Recruit Count
143
Registration Number
NCT03310073
Locations
🇮🇩

Hasan Sadikin Hospital, Bandung, West Java, Indonesia

Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Adults and Children (Phase I)

Phase 1
Completed
Conditions
Safety Issues
Interventions
Biological: Vi-DT (Bio Farma)
Biological: Vi polysaccharide vaccine
Biological: Influenzae vaccine
Biological: Pneumococcal conjugate vaccine
First Posted Date
2017-04-12
Last Posted Date
2018-03-06
Lead Sponsor
PT Bio Farma
Target Recruit Count
100
Registration Number
NCT03109600
Locations
🇮🇩

Jatinegara Primary Health Center, Jakarta, Indonesia

🇮🇩

Puskesmas Jatinegara, Jakarta, DKI Jaya, Indonesia

Antibody Persistence, Immune Response and Safety After Doses of Pentabio Vaccine

Phase 2
Completed
Conditions
Healthy
Interventions
Biological: Pentavalen
First Posted Date
2014-03-24
Last Posted Date
2014-12-18
Lead Sponsor
PT Bio Farma
Target Recruit Count
399
Registration Number
NCT02095314
Locations
🇮🇩

Tebet Primary Health Center, Jakarta, Indonesia

🇮🇩

Puter Primary Health Centre, Bandung, West Java, Indonesia

🇮🇩

Garuda Primary Health Center, Bandung, West Java, Indonesia

and more 3 locations

Evaluation on Immunogenicity and Safety Profile of Trivalent OPV (tOPV Bio Farma)

Phase 2
Completed
Conditions
Healthy
Interventions
Biological: tOPV commercial batch
Biological: tOPV pilot batch
First Posted Date
2014-03-20
Last Posted Date
2014-03-20
Lead Sponsor
PT Bio Farma
Target Recruit Count
240
Registration Number
NCT02093273
Locations
🇮🇩

Ibrahim Adjie Primary Health Centre, Bandung, West Java, Indonesia

🇮🇩

Garuda Primary Health Center, Bandung, West Java, Indonesia

🇮🇩

Puter Primary Health Centre, Bandung, West Java, Indonesia

and more 1 locations

Safety Profile Following Pentabio Vaccination in Indonesian Infants

Completed
Conditions
Healthy
First Posted Date
2014-03-20
Last Posted Date
2017-11-06
Lead Sponsor
PT Bio Farma
Target Recruit Count
4000
Registration Number
NCT02093286
Locations
🇮🇩

West Nusa Tenggara Provincial Ministry of Health, Mataram, West Nusa Tenggara, Indonesia

🇮🇩

Bali Provincial Ministry of Health, Bali, Indonesia

🇮🇩

Yogyakarta Provincial Ministry of Health, Yogyakarta, Indonesia

and more 1 locations

Immunogenocity and Safety of Flubio (Influenza HA) Vaccine in Infants and Children (Bridging Study)

Phase 2
Completed
Conditions
Healthy
Interventions
Biological: Vaccine
First Posted Date
2014-03-20
Last Posted Date
2015-04-29
Lead Sponsor
PT Bio Farma
Target Recruit Count
405
Registration Number
NCT02093260
Locations
🇮🇩

Jatinegara Primary Health Center, Jakarta, Indonesia

🇮🇩

Primary School of SDN 01 Kampung Melayu, Jakarta, Indonesia

Immunogenicity and Safety of DTP/HB/Hib (Bio Farma)Compared to DTP/HB Given Simultaneously With Hib(Registered)Vaccine

Phase 2
Completed
Conditions
Healthy
Interventions
Biological: DTP/HB and Hib vaccine
Biological: DTP/HB/Hib vaccine
First Posted Date
2013-11-18
Last Posted Date
2013-11-18
Lead Sponsor
PT Bio Farma
Target Recruit Count
220
Registration Number
NCT01986322
Locations
🇮🇩

Garuda Primary Health Center, Bandung, West Java, Indonesia

🇮🇩

Ibrahim Adji Primary Health Care Center, Bandung, West Java, Indonesia

🇮🇩

Puter Primary Health Center, Bandung, West Java, Indonesia

© Copyright 2025. All Rights Reserved by MedPath